Safety Profile -- Abstract O-026 (IMAGE)

European Society for Medical Oncology

Safety Profile -- Abstract O-026

Caption

Safety profile -- Abstract O-026 'Results of REARRANGE trial: A randomized phase 2 study comparing different dosing approaches for regorafenib (REG) during the first cycle of treatment in patients (pts) with metastatic colorectal cancer (mCRC)'

Credit

European Society for Medical Oncology

Usage Restrictions

The image may only be used with appropriate caption or credit

License

Licensed content

Disclaimer: AAAS and EurekAlert! are not responsible for the accuracy of news releases posted to EurekAlert! by contributing institutions or for the use of any information through the EurekAlert system.